(24MTHS)VIT-0910 International Randomised Phase II Trial of the Combinations of Vincristine and Irinotecan with or without Temozolomide (VI or VIT) in Patients with Refractory or Relapsed Rhabdomyosarcoma

Project Details

Short title(24MTHS)VIT-0910 International Randomised Phase II Trial of the Combinations of Vincristine and Irinotecan with or without Temozolomide (VI or VIT) in Patients with Refractory or Relapsed Rhabdomyosarcoma
StatusFinished
Effective start/end date1/05/1230/04/17

Funding

  • Cancer Research Uk